Until Labs is pioneering controlled-rate freezers and cryoprotectants to achieve reversible cryopreservation, allowing tissues to enter a glassy state rather than freezing. This technology aims to extend the viability of organs for transplantation, potentially transforming the landscape of organ donation and medical treatment for end-stage organ diseases.